{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T07:00:04Z","timestamp":1791442804747,"version":"4.3.3"},"reference-count":67,"publisher":"eLife Sciences Publications, Ltd","license":[{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2022,8,16]],"date-time":"2022-08-16T00:00:00Z","timestamp":1660608000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Sanofi","award":["Research grant from Sanofi"],"award-info":[{"award-number":["Research grant from Sanofi"]}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"crossref","award":["R01NS110354"],"award-info":[{"award-number":["R01NS110354"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elifesciences.org"],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,7,8]]},"abstract":"<jats:sec id=\"abs1\">\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>\n                      Neuronopathic Gaucher disease (nGD) is a rare neurodegenerative disorder caused by biallelic mutations in\n                      <jats:italic>GBA<\/jats:italic>\n                      and buildup of glycosphingolipids in lysosomes. Neuronal injury and cell death are prominent pathological features; however, the role of\n                      <jats:italic>GBA<\/jats:italic>\n                      in individual cell types and involvement of microglia, blood-derived macrophages, and immune infiltrates in nGD pathophysiology remains enigmatic.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs2\">\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Here, using single-cell resolution of mouse nGD brains, lipidomics, and newly generated biomarkers, we found induction of neuroinflammation pathways involving microglia, NK cells, astrocytes, and neurons.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs3\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Targeted rescue of\n                      <jats:italic>Gba<\/jats:italic>\n                      in microglia and neurons, respectively, in\n                      <jats:italic>Gba<\/jats:italic>\n                      -deficient, nGD mice reversed the buildup of glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph), concomitant with amelioration of neuroinflammation, reduced serum neurofilament light chain (Nf-L), and improved survival. Serum GlcSph concentration was correlated with serum Nf-L and ApoE in nGD mouse models as well as in GD patients.\n                      <jats:italic>Gba<\/jats:italic>\n                      rescue in microglia\/macrophage compartment prolonged survival, which was further enhanced upon treatment with brain-permeant inhibitor of glucosylceramide synthase, effects mediated via improved glycosphingolipid homeostasis, and reversal of neuroinflammation involving activation of microglia, brain macrophages, and NK cells.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs4\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Together, our study delineates individual cellular effects of\n                      <jats:italic>Gba<\/jats:italic>\n                      deficiency in nGD brains, highlighting the central role of neuroinflammation driven by microglia activation. Brain-permeant small-molecule inhibitor of glucosylceramide synthase reduced the accumulation of bioactive glycosphingolipids, concomitant with amelioration of neuroinflammation involving microglia, NK cells, astrocytes, and neurons. Our findings advance nGD disease biology whilst identifying compelling biomarkers of nGD to improve patient management, enrich clinical trials, and illuminate therapeutic targets.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"abs5\">\n                    <jats:title>Funding:<\/jats:title>\n                    <jats:p>Research grant from Sanofi; other support includes R01NS110354.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7554\/elife.79830","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T06:15:51Z","timestamp":1657692951000},"update-policy":"https:\/\/doi.org\/10.7554\/elife.79830","source":"Crossref","is-referenced-by-count":56,"title":["Neuroinflammation in neuronopathic Gaucher disease: Role of microglia and NK cells, biomarkers, and response to substrate reduction therapy"],"prefix":"10.7554","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-7973","authenticated-orcid":true,"given":"Chandra Sekhar","family":"Boddupalli","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v76x132","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Internal Medicine, Yale School of Medicine","place":["New Haven, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4081-7811","authenticated-orcid":true,"given":"Shiny","family":"Nair","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v76x132","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Internal Medicine, Yale School of Medicine","place":["New Haven, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn","family":"Belinsky","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v76x132","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Internal Medicine, Yale School of Medicine","place":["New Haven, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Gans","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erin","family":"Teeple","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tri-Hung","family":"Nguyen","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameet","family":"Mehta","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v76x132","id-type":"ROR","asserted-by":"publisher"}],"name":"Yale Center for Genome Analysis, Yale School of Medicine","place":["New Haven, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilu","family":"Guo","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin L","family":"Kramer","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiapeng","family":"Ruan","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v76x132","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Internal Medicine, Yale School of Medicine","place":["New Haven, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honggge","family":"Wang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Davison","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinesh","family":"Kumar","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DJ","family":"Vidyadhara","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v76x132","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Neuroscience, Yale School of Medicine","place":["New Haven, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailin","family":"Zhang","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Klinger","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/027vj4x92","id-type":"ROR","asserted-by":"publisher"}],"name":"Translational Sciences, Sanofi","place":["Framingham, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3447-6421","authenticated-orcid":true,"given":"Pramod K","family":"Mistry","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03v76x132","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Internal Medicine, Yale School of Medicine","place":["New Haven, United States"]},{"id":[{"id":"https:\/\/ror.org\/03v76x132","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Molecular & Cellular Physiology, Yale School of Medicine","place":["New Haven, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4374","published-online":{"date-parts":[[2022,8,16]]},"reference":[{"key":"bib1","doi-asserted-by":"publisher","DOI":"10.1212\/NXG.0000000000000158","article-title":"Previously unrecognized behavioral phenotype in Gaucher disease type 3","volume":"3","author":"Abdelwahab","year":"2017","journal-title":"Neurology. Genetics"},{"key":"bib2","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1007\/s10545-011-9308-6","article-title":"Biomarkers in the diagnosis of lysosomal storage disorders: proteins, lipids, and inhibodies","volume":"34","author":"Aerts","year":"2011","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"bib3","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.ymgme.2019.07.014","article-title":"Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease","volume":"128","author":"Afinogenova","year":"2019","journal-title":"Molecular Genetics and Metabolism"},{"key":"bib4","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1056\/NEJMoa033277","article-title":"Mutations in the glucocerebrosidase gene and Parkinson\u2019s disease in Ashkenazi Jews","volume":"351","author":"Aharon-Peretz","year":"2004","journal-title":"The New England Journal of Medicine"},{"key":"bib5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-14198-8","article-title":"Identification of region-specific astrocyte subtypes at single cell resolution","volume":"11","author":"Batiuk","year":"2020","journal-title":"Nature Communications"},{"key":"bib6","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-020-00408-1","article-title":"Glycosphingolipids and neuroinflammation in Parkinson\u2019s disease","volume":"15","author":"Belarbi","year":"2020","journal-title":"Molecular Neurodegeneration"},{"key":"bib7","article-title":"Microglia: The brain\u2019s first responders","volume":"1","author":"Bilbo","year":"2017","journal-title":"Cerebrum: The Dana Forum on Brain Science"},{"key":"bib8","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1111\/jnc.15136","article-title":"Substrate reduction therapy using Genz-667161 reduces levels of pathogenic components in a mouse model of neuronopathic forms of Gaucher disease","volume":"156","author":"Blumenreich","year":"2021","journal-title":"Journal of Neurochemistry"},{"key":"bib9","doi-asserted-by":"publisher","first-page":"1814","DOI":"10.1096\/fj.02-0149fje","article-title":"Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide","volume":"16","author":"Bodennec","year":"2002","journal-title":"FASEB Journal"},{"key":"bib10","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10545-010-9055-0","article-title":"The risk of Parkinson\u2019s disease in type 1 Gaucher disease","volume":"33","author":"Bultron","year":"2010","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"bib11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043310","article-title":"Systemic delivery of a glucosylceramide synthase inhibitor reduces CNS substrates and increases lifespan in a mouse model of type 2 Gaucher disease","volume":"7","author":"Cabrera-Salazar","year":"2012","journal-title":"PLOS ONE"},{"key":"bib12","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20202717","article-title":"Microglia in Alzheimer\u2019s disease at single-cell level: Are there common patterns in humans and mice?","volume":"218","author":"Chen","year":"2021","journal-title":"The Journal of Experimental Medicine"},{"key":"bib13","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000026036","article-title":"The value of long noncoding RNAs for predicting the recurrence of endometriosis: A protocol for meta-analysis and bioinformatics analysis","volume":"100","author":"Chen","year":"2021","journal-title":"Medicine"},{"key":"bib14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/jnc.14483","article-title":"Absence of infiltrating peripheral myeloid cells in the brains of mouse models of lysosomal storage disorders","volume":"148","author":"Cho","year":"2019","journal-title":"Journal of Neurochemistry"},{"key":"bib15","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1126\/science.7716543","article-title":"Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells","volume":"268","author":"Colonna","year":"1995","journal-title":"Science"},{"key":"bib16","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.1016\/S0140-6736(00)02161-9","article-title":"Novel oral treatment of Gaucher\u2019s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis","volume":"355","author":"Cox","year":"2000","journal-title":"Lancet"},{"key":"bib17","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/s0166-4328(01)00280-7","article-title":"Genetic dissection of mouse exploratory behaviour","volume":"125","author":"Crusio","year":"2001","journal-title":"Behavioural Brain Research"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.cell.2018.12.022","article-title":"Natural killer cells degenerate intact sensory afferents following nerve injury","volume":"176","author":"Davies","year":"2019","journal-title":"Cell"},{"key":"bib19","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7777","article-title":"Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles","volume":"7","author":"Dick","year":"2022","journal-title":"Science Immunology"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"17483","DOI":"10.1073\/pnas.0708086104","article-title":"Murine models of acute neuronopathic Gaucher disease","volume":"104","author":"Enquist","year":"2007","journal-title":"PNAS"},{"key":"bib21","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1242\/dmm.008185","article-title":"Animal models for Gaucher disease research","volume":"4","author":"Farfel-Becker","year":"2011","journal-title":"Disease Models & Mechanisms"},{"key":"bib22","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0844-5","article-title":"MAST: a flexible statistical framework for assessing transcriptional changes and characterizing heterogeneity in single-cell RNA sequencing data","volume":"16","author":"Finak","year":"2015","journal-title":"Genome Biology"},{"key":"bib23","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1136\/jnnp-2018-320106","article-title":"Neurofilament light chain as a biomarker in neurological disorders","volume":"90","author":"Gaetani","year":"2019","journal-title":"Journal of Neurology, Neurosurgery, and Psychiatry"},{"key":"bib24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2022.105663","article-title":"Glucocerebrosidase-associated Parkinson disease: Pathogenic mechanisms and potential drug treatments","volume":"166","author":"Gegg","year":"2022","journal-title":"Neurobiology of Disease"},{"key":"bib25","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ymgme.2020.12.291","article-title":"Gaucher disease: Basic and translational science needs for more complete therapy and management","volume":"132","author":"Grabowski","year":"2021","journal-title":"Molecular Genetics and Metabolism"},{"key":"bib26","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","article-title":"Disease-associated astrocytes in Alzheimer\u2019s disease and aging","volume":"23","author":"Habib","year":"2020","journal-title":"Nature Neuroscience"},{"key":"bib27","first-page":"833","volume-title":"In Advances in Neural Information Processing Systems","author":"Hinton","year":"2002"},{"key":"bib28","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.immuni.2020.11.003","article-title":"The sppl3-defined glycosphingolipid repertoire orchestrates hla class i-mediated immune responses","volume":"54","author":"Jongsma","year":"2021","journal-title":"Immunity"},{"key":"bib29","first-page":"627","article-title":"The Gaucher mouse","volume":"95","author":"Kanfer","year":"1982","journal-title":"Progress in Clinical and Biological Research"},{"key":"bib30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1038\/358066a0","article-title":"MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells","volume":"358","author":"Karlhofer","year":"1992","journal-title":"Nature"},{"key":"bib31","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-14612-6","article-title":"Serum neurofilament light levels in normal aging and their association with morphologic brain changes","volume":"11","author":"Khalil","year":"2020","journal-title":"Nature Communications"},{"key":"bib32","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1002\/2211-5463.12078","article-title":"Elevation of glycoprotein nonmetastatic melanoma protein B in type 1 Gaucher disease patients and mouse models","volume":"6","author":"Kramer","year":"2016","journal-title":"FEBS Open Bio"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-62703-520-0_3","article-title":"Microglia isolation from adult mouse brain","volume":"1041","author":"Lee","year":"2013","journal-title":"Methods in Molecular Biology"},{"key":"bib34","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00579","article-title":"Neurofilament-light chain as biomarker of neurodegenerative and rare diseases with high translational value","volume":"14","author":"Loeffler","year":"2020","journal-title":"Frontiers in Neuroscience"},{"key":"bib35","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1093\/brain\/awh655","article-title":"Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis","volume":"129","author":"Mahad","year":"2006","journal-title":"Brain"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/s41590-020-0654-0","article-title":"Transcriptional profiling and therapeutic targeting of oxidative stress in neuroinflammation","volume":"21","author":"Mendiola","year":"2020","journal-title":"Nature Immunology"},{"key":"bib37","doi-asserted-by":"publisher","first-page":"19473","DOI":"10.1073\/pnas.1003308107","article-title":"Glucocerebrosidase gene-deficient mouse recapitulates Gaucher disease displaying cellular and molecular dysregulation beyond the macrophage","volume":"107","author":"Mistry","year":"2010","journal-title":"PNAS"},{"key":"bib38","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1073\/pnas.1400768111","article-title":"Glucocerebrosidase 2 gene deletion rescues type 1 Gaucher disease","volume":"111","author":"Mistry","year":"2014","journal-title":"PNAS"},{"key":"bib39","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1002\/ajh.24801","article-title":"Transformation in pretreatment manifestations of Gaucher disease type 1 during two decades of alglucerase\/imiglucerase enzyme replacement therapy in the International Collaborative Gaucher Group (ICGG) Gaucher Registry","volume":"92","author":"Mistry","year":"2017","journal-title":"American Journal of Hematology"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1002\/ajh.24877","article-title":"Outcomes after 18 months of eliglustat therapy in treatment-na\u00efve adults with Gaucher disease type 1: The phase 3 ENGAGE trial","volume":"92","author":"Mistry","year":"2017","journal-title":"American Journal of Hematology"},{"key":"bib41","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/ajh.24491","article-title":"Glucosylsphingosine is a key biomarker of Gaucher disease","volume":"91","author":"Murugesan","year":"2016","journal-title":"American Journal of Hematology"},{"key":"bib42","doi-asserted-by":"publisher","first-page":"E3285","DOI":"10.1073\/pnas.1618133114","article-title":"Intracellular metabolite \u03b2-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity","volume":"114","author":"Nagata","year":"2017","journal-title":"PNAS"},{"key":"bib43","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1182\/blood-2014-09-600270","article-title":"Type II NKT-TFH cells against Gaucher lipids regulate B-cell immunity and inflammation","volume":"125","author":"Nair","year":"2015","journal-title":"Blood"},{"key":"bib44","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1056\/NEJMoa1508808","article-title":"Clonal immunoglobulin against lysolipids in the origin of myeloma","volume":"374","author":"Nair","year":"2016","journal-title":"The New England Journal of Medicine"},{"key":"bib45","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature21368","article-title":"Complement drives glucosylceramide accumulation and tissue inflammation in Gaucher disease","volume":"543","author":"Pandey","year":"2017","journal-title":"Nature"},{"key":"bib46","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-018-0025-4","article-title":"Lysosomal storage diseases","volume":"4","author":"Platt","year":"2018","journal-title":"Nature Reviews. Disease Primers"},{"key":"bib47","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data","volume":"33","author":"Satija","year":"2015","journal-title":"Nature Biotechnology"},{"key":"bib48","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1002\/ana.21491","article-title":"Randomized, controlled trial of miglustat in Gaucher\u2019s disease type 3","volume":"64","author":"Schiffmann","year":"2008","journal-title":"Annals of Neurology"},{"key":"bib49","doi-asserted-by":"publisher","first-page":"S144","DOI":"10.1016\/j.ymgme.2019.11.382","article-title":"Venglustat combined with imiglucerase positively affects neurological features and brain connectivity in adults with Gaucher disease type 3","volume":"129","author":"Schiffmann","year":"2020","journal-title":"Molecular Genetics and Metabolism"},{"key":"bib50","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/S1474-4422(20)30412-9","article-title":"APOE and Alzheimer\u2019s disease: advances in genetics, pathophysiology, and therapeutic approaches","volume":"20","author":"Serrano-Pozo","year":"2021","journal-title":"The Lancet. Neurology"},{"key":"bib51","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1358\/dof.2010.35.8.1505566","article-title":"Eliglustat tartrate: Glucosylceramide synthase inhibitor treatment of type 1 gaucher disease","volume":"35","author":"Shayman","year":"2010","journal-title":"Drugs of the Future"},{"key":"bib52","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abl9945","article-title":"Treatment of a genetic brain disease by CNS-wide microglia replacement","volume":"14","author":"Shibuya","year":"2022","journal-title":"Science Translational Medicine"},{"key":"bib53","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3233\/JAD-201295","article-title":"The effect of gba mutations and apoe polymorphisms on dementia with lewy bodies in ashkenazi jews","volume":"80","author":"Shiner","year":"2021","journal-title":"Journal of Alzheimer\u2019s Disease"},{"key":"bib54","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJMoa0901281","article-title":"Multicenter analysis of glucocerebrosidase mutations in Parkinson\u2019s disease","volume":"361","author":"Sidransky","year":"2009","journal-title":"The New England Journal of Medicine"},{"key":"bib55","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1016\/S1474-4422(12)70190-4","article-title":"The link between the GBA gene and parkinsonism","volume":"11","author":"Sidransky","year":"2012","journal-title":"The Lancet. Neurology"},{"key":"bib56","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1084\/jem.20101643","article-title":"Dynamic variation in cycling of hematopoietic stem cells in steady state and inflammation","volume":"208","author":"Takizawa","year":"2011","journal-title":"The Journal of Experimental Medicine"},{"key":"bib57","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-020-01934-x","article-title":"Mice defective in interferon signaling help distinguish between primary and secondary pathological pathways in a mouse model of neuronal forms of Gaucher disease","volume":"17","author":"Vardi","year":"2020","journal-title":"Journal of Neuroinflammation"},{"key":"bib58","doi-asserted-by":"publisher","DOI":"10.1088\/1742-5468\/2008\/10\/P10008","article-title":"Fast unfolding of communities in large networks","volume":"10","author":"Vincent","year":"2008","journal-title":"Journal of Statistical Mechanics"},{"key":"bib59","doi-asserted-by":"publisher","first-page":"3583","DOI":"10.1093\/hmg\/ddq273","article-title":"Altered expression and distribution of cathepsins in neuronopathic forms of Gaucher disease and in other sphingolipidoses","volume":"19","author":"Vitner","year":"2010","journal-title":"Human Molecular Genetics"},{"key":"bib60","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1517\/14728222.2014.981530","article-title":"Emerging therapeutic targets for Gaucher disease","volume":"19","author":"Vitner","year":"2015","journal-title":"Expert Opinion on Therapeutic Targets"},{"key":"bib61","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/ni1523","article-title":"Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor","volume":"8","author":"Walzer","year":"2007","journal-title":"Nature Immunology"},{"key":"bib62","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200785","article-title":"Anti-human TREM2 induces microglia proliferation and reduces pathology in an Alzheimer\u2019s disease model","volume":"217","author":"Wang","year":"2020","journal-title":"The Journal of Experimental Medicine"},{"key":"bib63","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22114-2","article-title":"Neurofilament light chain as a potential biomarker for monitoring neurodegeneration in X-linked adrenoleukodystrophy","volume":"12","author":"Weinhofer","year":"2021","journal-title":"Nature Communications"},{"key":"bib64","doi-asserted-by":"publisher","first-page":"3464","DOI":"10.1021\/acschemneuro.0c00558","article-title":"Optimization of eliglustat-based glucosylceramide synthase inhibitors as substrate reduction therapy for gaucher disease type 3","volume":"11","author":"Wilson","year":"2020","journal-title":"ACS Chemical Neuroscience"},{"key":"bib65","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ymgme.2004.04.011","article-title":"Neuropathology provides clues to the pathophysiology of Gaucher disease","volume":"82","author":"Wong","year":"2004","journal-title":"Molecular Genetics and Metabolism"},{"key":"bib66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.immuni.2012.12.001","article-title":"Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis","volume":"38","author":"Yona","year":"2013","journal-title":"Immunity"},{"key":"bib67","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0120194","article-title":"Identification of a biomarker in cerebrospinal fluid for neuronopathic forms of Gaucher disease","volume":"10","author":"Zigdon","year":"2015","journal-title":"PLOS ONE"}],"container-title":["eLife"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/cdn.elifesciences.org\/articles\/79830\/elife-79830-v3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/cdn.elifesciences.org\/articles\/79830\/elife-79830-v3.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/elifesciences.org\/articles\/79830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T09:46:07Z","timestamp":1710236767000},"score":1,"resource":{"primary":{"URL":"https:\/\/elifesciences.org\/articles\/79830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,16]]},"references-count":67,"alternative-id":["10.7554\/eLife.79830"],"URL":"https:\/\/doi.org\/10.7554\/elife.79830","archive":["CLOCKSS"],"relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2022.05.13.491834","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2022.05.13.491834","asserted-by":"subject"},{"id-type":"doi","id":"10.1101\/2022.05.13.491834","asserted-by":"object"}],"is-supplemented-by":[{"id-type":"accession","id":"GSE207766","asserted-by":"subject"},{"id-type":"accession","id":"GSE207768","asserted-by":"subject"},{"id-type":"accession","id":"GSE207765","asserted-by":"subject"}],"has-review":[{"id-type":"doi","id":"10.7554\/eLife.79830.sa2","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.79830.sa0","asserted-by":"object"},{"id-type":"doi","id":"10.7554\/eLife.79830.sa1","asserted-by":"object"}]},"ISSN":["2050-084X"],"issn-type":[{"value":"2050-084X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,16]]},"assertion":[{"value":"single anonymised","name":"peer_review_transparency","label":"Peer review transparency","group":{"name":"peer_review_taxonomy"}},{"value":"other reviewer(s), editor","name":"peer_review_interaction","label":"Peer review interaction","group":{"name":"peer_review_taxonomy"}},{"value":"review summaries, review reports, author\/editor communication, reviewer identities reviewer opt in, editor identities","name":"peer_review_published","label":"Peer review published","group":{"name":"peer_review_taxonomy"}},{"value":"open (sign in with ORCID iD required)","name":"post_publication_commenting","label":"Post publication commenting","group":{"name":"post_publication_commenting"}}],"article-number":"e79830"}}